As one of the latest weight loss peptides, Retatrutide’s triple receptor activation has attracted the attention of many Semaglutide users and Tirzpatide users. At the same time, like Semaglutide, it acts on GLP-1 receptors, and like Tirzpatide, it acts on GLP-1 receptors and GIP receptors. As a result, users tend to experience fewer side effects when they switch to Retatrutide, …

Many people are concerned about the latest weight loss product Retatrutide, and some people are already using it to lose weight. However, Retatrutide is still a drug under trials, so why buy it for weight loss? Weight loss effects of Retatrutide As a three-receptor agonist, Retatrutide’s weight loss effect was demonstrated in its Phase 2 trial. After 48 weeks of …